A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Pelvic inflammatory disease (PID) is an infection of any of a woman's pelvic organs, including the uterus, ovaries, or fallopian tubes, or the peritoneum (the membrane covering the abdominal cavity). One million women are diagnosed with PID annually in the United States, usually resulting from a sexually transmitted infection such as chlamydia or gonorrhea. Acute PID comes on suddenly and tends to be more severe, whereas chronic PID is a low grade infection that may cause only mild pain and sometimes backache. If not treated promptly, PID can result in infertility and, in rare cases, death.
Acute PID is accompanied by the following signs and symptoms:
Chronic PID is accompanied by the following signs and symptoms:
PID occurs when bacteria from the vagina or cervix infiltrate the normally sterile pelvic organs. PID is most commonly cause by sexually transmitted diseases (STDs), such as Chlamydia trachomatis and Neisseria gonorrhoeae.
People with the following conditions or characteristics are at risk for developing PID:
If you are experiencing symptoms associated with PID, you should see your health care provider. A combination of a physical exam, lab tests, imaging, including ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI). Other procedures may also be performed to make a diagnosis. In some cases, your physician may order laparoscopic evaluation.
Barrier methods of birth control (condoms, diaphragms, vaginal spermicides) reduce the risk of PID. Rapid diagnosis and effective treatment of lower urinary tract infections can help prevent PID from developing. Experts recommend routine screening for infections in high risk individuals.
Your health care provider may recommend hospitalization or outpatient treatment with follow up. Outpatient therapy consists of rest and medications. Patients being treated for PID should abstain from sexual intercourse throughout the course of treatment. It is essential to evaluate and treat male sex partners.
Your provider may prescribe the following antibiotics or combination of drugs:
Some conditions, such as an abscess in the ovary or fallopian tube, may make surgery necessary.
A comprehensive treatment plan for PID may include a range of complementary and alternative therapies. PID can lead to serious complications. Complementary therapies should be used only in conjunction with conventional medical interventions. Keep all of your prescribing doctors informed about any supplements or therapies you may be using.
You may address nutritional deficiencies with the following supplements:
Herbs are generally a safe way to strengthen and tone the body's systems. As with any therapy, you should work with your health care provider to diagnose your problem before starting any treatment. You may use herbs as dried extracts (capsules, powders, teas), glycerites (glycerine extracts), or tinctures (alcohol extracts). Unless otherwise indicated, make teas with 1 tsp. herb per cup of hot water. Steep covered 5 - 10 minutes for leaf or flowers, and 10 - 20 minutes for roots. Drink 2 - 4 cups per day. You may use tinctures alone or in combination as noted.
Castor Oil Packs
Dampen a cloth with castor oil, and apply to the abdomen. Cover with saran wrap, then apply a heating pad over this pack. Used for 1 - 3 hours, castor oil packs can reduce cramping and pain in some patients. Do not use caster oil packs during the acute phase of PID.
Acupuncture may help enhance immune function and reduce pain and inflammation, especially with chronic PID. Acupuncturists often will gear their protocols at draining what they call “Damp Heat” from the area. This is done using both acupuncture and Chinese herbal preparations.
In 85% of cases, the initial treatment succeeds. In 75% of cases, patients do not experience a recurrence of the infection. However, when there is a recurrence, the likelihood of infertility increases with each episode of PID. Potential complications from PID include:
Your health care provider will schedule a follow up visit 48 - 72 hours after treatment is started. If you are diagnosed with PID, you should inform any sexual partners so that they can be examined and treated if the infection has been transmitted.
Bope: Conn's Current Therapy 2010, 1st ed. Philadelphia, PA: Saunders Elsevier. 2009.
Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea--a review. J Am Coll Nutr. 2006;25(2):79-99.
Crossman SH. The challenge of pelvic inflammatory disease. Am Fam Physician. 2006;73(5):859-64.
Cvetnic Z, Vladimir-Knezevic S. Antimicrobial activity of grapefruit seed and pulp ethanolic extract. Acta Pharm. 2004;54(3):243-50.
Das M, Sur P, Gomes A, Vedasiromoni JR, Ganguly DK. Inhibition of tumor growth and inflammation by consumption of tea. Phytother Res. 2002;16 Suppl 1:S40-4.
Ferri: Ferri's Clinical Advisor, 2010, 1st ed. Philadelphia, PA: Mosby Elsevier. 2009.
Gonclaves C, Dinis T, Batista MT. Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: a mechanism for anti-inflammatory activity. Phytochemistry. 2005;66(1):89-98.
Haggerty CL, Ness RB. Epidemiology, pathogenesis and treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther. 2006;4(2):235-47.
Hale LP, Greer PK, Trinh CT, James CL. Proteinase activity and stability of natural bromelain preparations. Int Immunopharmacol. 2005;5(4):783-93.
Heggers JP, Cottingham J, Gussman J, et al. The effectiveness of processed grapefruit-seed extract as an antibacterial agent: II. Mechanism of action and in vitro toxicity. J Altern Complement Med. 2002;8(3):333-40.
Heitzman ME, Neto CC, Winiarz E, Vaisberg AJ, Hammond GB. Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae). Phytochemistry. 2005;66(1):5-29.
Ibarrola Vidaurre M, Benito J, Azcona B, Zubeldia N. Infectious pathology: vulvovaginitis, sexually transmitted diseases, pelvic inflammatory disease, tubo-ovarian abscesses. An Sist Sanit Navar. 2009;32,Suppl 1: 29-38.
Lareau S, Beigi R. Pelvic Inflammatory Disease and Tubo-ovarian Abscess. Infectious Disease Clinics of North America. 22(4).
Long: Principles and Practice of Pediatric Infectious Diseases, 3rd ed. Philadelphia, PA: Churchill Livingstone, 2008. Ch. 56.
Martinez F, Lopez-Arregui E. Infection risk and intrauterine devices. Acta Obstet Gynecol Scand. 2009;88(3):246-50.
Risser JM, Risser WL. Purulent vaginal and cervical discharge in the diagnosis of pelvic inflammatory disease. Int J STD AIDS. 2009;20(2):73-6.
Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J. 2005;46(5):585-96.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885